0001209191-19-032432.txt : 20190523 0001209191-19-032432.hdr.sgml : 20190523 20190523181156 ACCESSION NUMBER: 0001209191-19-032432 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190523 FILED AS OF DATE: 20190523 DATE AS OF CHANGE: 20190523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRYSKA DAVID W CENTRAL INDEX KEY: 0001202335 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 19851458 MAIL ADDRESS: STREET 1: 749 N MARY AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-23 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001202335 GRYSKA DAVID W C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400 DURHAM NC 27703 1 0 0 0 Common Stock 2019-05-23 4 A 0 1750 0.00 A 1750 D Common Stock 1996 I By the Gryska Family Trust Stock Option (right to buy) 39.44 2019-05-23 4 A 0 7800 0.00 A 2029-05-23 Common Stock 7800 7800 D Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on May 23, 2020. Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of May 23, 2019. /s/ John LaRocca, Attorney-in-Fact for David W. Gryska 2019-05-23